Genomics Sells Nearly 30,000 Shares: Investor Signal for Genomics Stocks
A CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
Evaluate wide market index fund performance against the SP 500 in retirement planning, emphasizing return consistency and fee impact.
28,313 articlesA CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
JPMorgan Chase posted a strong quarterly beat, led by a surge in equity-markets revenue and higher net interest incom...
Citi's leadership under Jane Fraser is embracing Buffett-inspired rules to manage friction, keep decisions measured, ...
Two $2 trillion companies are anchoring Intel’s AI roadmap with a $5 billion NVIDIA investment and a multiyear Google...
A memory-focused stock surged from about $40 to near $2,000 this year, fueling debate over whether the run can endure...
Tesla stock has slid about 18% from its December peak as deliveries declined and autonomy safety metrics raise questi...
Victoria’s Secret defies doubters by ditching perpetual sales and a woke marketing tone, posting stronger-than-expect...
As housing activity cools, real estate agents should rethink how they measure success. This report explains why chasi...
A January 2026 FHFA release details a two-score, lender-choice framework that could ripple through mortgage pricing, ...
When a Harmonic director sold 4,300 shares, it sparked questions about the stock’s outlook. This guide breaks down in...
Semiconductor ETFs are leading the charge on U.S. exchanges, pushing chip-focused funds onto the most-traded lists. T...
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...